Form 4: Tandem Diabetes Care Executive Exercises Stock Options, Sells Shares for Tax Obligations

Mark David Novara, EVP & Chief Commercial Officer at Tandem Diabetes Care, exercised stock options and sold shares to cover tax obligations on December 16, 2024.

Summary

• Mark David Novara, an executive at Tandem Diabetes Care, exercised 29,658 restricted stock units (RSUs) on December 16, 2024.
• These RSUs converted into common stock.
• Following the exercise, 10,732 shares were withheld by the company to cover tax obligations.
• The shares were withheld at a price of $32.66 per share.
• No shares were sold on the open market.
• After these transactions, Novara directly owns 19,458 shares of Tandem Diabetes Care common stock and 59,317 RSUs.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. There is no indication of positive or negative sentiment, it is a neutral event.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for companies to withhold shares to cover tax obligations when stock options or restricted stock units vest.

Comparison to Industry Standards

• Stock-based compensation is a common practice across the technology and medical device industries.
• The vesting schedule of the RSUs, with a portion vesting initially and the remainder over subsequent quarters, is typical for executive compensation packages.
• The tax withholding process is standard practice to ensure compliance with tax regulations.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard executive compensation event.
• The withholding of shares for tax purposes does not affect the company's financial position.

Key Dates

Keywords

Tandem Diabetes Care, stock options, restricted stock units, executive compensation, insider trading, Form 4, TNDM